8-K - VistaGen Therapeutics, Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

On March 5, 2026, VistaGen Therapeutics, Inc. implemented a Board-approved reduction in its workforce by approximately 20%. This action was disclosed in an 8-K filing on March 11, 2026, under Item 8.01 Other Events.

Key Takeaways

1Workforce reduced by approximately 20% on March 5, 2026

2Reduction approved by the Board of Directors

3Filed as Form 8-K on March 11, 2026

Current Report Details

Event Type

Other Event

Disclosure

Voluntary

Variant

8-K

Items Reported

8.01

Other Events On March 5, 2026, Vistagen Therapeutics, Inc. (the “ Company ”) implemented a Board approved reduction in its workforce by approximately 20%. The r

Other Event

Exhibits (1)

8-K